Purdue Opioid Settlement 2026: the $7.4 Billion Payout — $16,294, $8,147 & $25,653 Victim Awards Explained
On May 1, 2026, the $7.4 billion Purdue opioid settlement took effect, and the victims' trust published exact award amounts: $16,294 for a top-tier claim, $8,147 for second-tier, and $25,653 for neonatal abstinence claims. Payments have begun on a rolling basis, but the window to file a new claim closed in July 2025 — only already-qualified claimants are in line.
Key Facts
- The settlement totals about $7.4 billion: up to $6.5 billion from members of the Sackler family paid over 15 years, plus $900 million from Purdue Pharma itself.
- Only a slice is reserved for individuals: a roughly $865 million pool run by the Purdue Personal Injury Trust, while most of the $7.4 billion funds government abatement programs.
- On September 30, 2026, the trust published initial award amounts: $16,294 for a Non-NAS Tier 1 claim, $8,147 for a Non-NAS Tier 2 claim, and $25,653 for a neonatal abstinence syndrome claim — before attorney fees and medical liens.
- The bankruptcy plan was confirmed November 18, 2025 and took effect May 1, 2026; Purdue dissolved, with its operations continuing under Knoa Pharma LLC.
- The window to file a new personal-injury claim closed July 28, 2025 — no new individual claimants can enter the process now.
How $7.4 Billion Got on the Table
A settlement is a binding agreement that resolves lawsuits without a trial. This one has a long prologue. Purdue Pharma, the maker of OxyContin, filed for bankruptcy protection in September 2019 under the weight of thousands of lawsuits from states, local governments, tribes, and individuals over its role in the opioid crisis — a crisis linked to some 900,000 U.S. overdose deaths since 1999. Purdue pleaded guilty to federal criminal charges in 2020 and was sentenced in April 2026.
The first settlement attempt collapsed. On June 27, 2024, the U.S. Supreme Court ruled 5-4 in Harrington v. Purdue Pharma that bankruptcy law does not permit releases that shield non-debtors — the Sackler family — without affected creditors' consent. Negotiators went back to work, and on January 23, 2025, a coalition of 15 states announced a new agreement in principle: $7.4 billion, larger than the original deal, with releases that are consensual rather than blanket. U.S. Bankruptcy Judge Sean Lane confirmed the plan on November 18, 2025, with overwhelming creditor support — only 218 of roughly 54,000 personal-injury victims voted against it. Fifty-five attorneys general representing all eligible states and territories signed on.
Where the Money Actually Goes
Almost all of the $7.4 billion is directed to governments and public entities for opioid abatement: addiction treatment, naloxone distribution, prevention, and recovery programs across the country, paid out over 15 years. That money is separate from the roughly $865 million pool reserved for individual personal-injury claimants. A state's abatement windfall does not translate into a check for any resident — the two streams are entirely distinct.
The split is the settlement's most criticized feature. Recovery advocate Ryan Hampton and others have called the victim compensation grossly inadequate relative to the scale of harm, noting the Sackler family reportedly made more than $35 billion from OxyContin over the years. Defenders answer that the plan was designed to end the crisis's pipeline of new victims, not to compensate every past one — and that individual awards were capped to keep the agreement from collapsing again.
What Individual Victims Actually Receive
The Purdue Personal Injury Trust administers the individual pool. On September 30, 2026, it posted its first claims-processing update with concrete figures, replacing years of estimates from lawyers and advocates. A Non-NAS Tier 1 claim is worth $16,294; a Non-NAS Tier 2 claim $8,147; and a neonatal abstinence syndrome claim $25,653. NAS — neonatal abstinence syndrome — is the withdrawal symptoms suffered by newborns exposed to opioids in the womb, and its tier carries the highest award because it reflects a lifetime of care costs.
Two caveats matter. First, those figures already reflect the trust's operating costs but are before the claimant's attorney fees and any medical liens, so the amount that arrives is usually lower. Second, they are initial distributions: the trust has said a second payment is possible once its remaining contingencies are resolved. The revised plan also lifted the minimum payment for qualifying claimants to $8,000, up from $3,500 under the old plan — though estimated payouts for families of overdose victims fell from as much as $48,000 to as little as $8,000, a tradeoff that angered some survivors.
Who Still Gets Paid — and Who Is Out
A proof of claim is the form a creditor files in a bankruptcy case to seek payment, and timing was everything here. Only people who filed a proof of claim in the Purdue bankruptcy by the July 30, 2020 deadline were ever eligible. Those claimants then had to submit a separate claim form to the trust by July 28, 2025. By late July 2025, about 63,000 individuals had submitted supporting evidence; in April 2026, a judge approved removing roughly 80,000 people who had missed earlier deadlines from any payout.
Claimants who granted the consensual third-party release by opting in before March 1, 2026 are being paid through the trust; those who did not opt in kept the right to sue but cannot be paid until 18 months after the effective date — that is, late 2027 at the earliest. Claimants with a lawyer are paid through their firm; those without one are being emailed to confirm a mailing address first. If you never filed a proof of claim in 2020, there is no late entry and no appeal: the door is closed.
The Payment Timeline
The plan went effective and was substantially consummated on May 1, 2026, and the trust was funded the same day. In its September 30, 2026 update, the trust said it had begun paying Qualified and Allowed claimants on a rolling basis and expects most of them to receive at least part of their award before the end of 2026. That is the year that matters: after seven years of bankruptcy, Supreme Court reversals, and renegotiation, the checks are finally moving. A second distribution would follow only after the trust resolves its remaining contingencies, with no date announced.
What People Get Wrong About This Settlement
Three misconceptions circulate. First, that the Sacklers admitted wrongdoing — they did not; the settlement resolves claims without any admission of liability, and no court has found any Sackler family member liable. Second, that every victim gets the headline number — the $7.4 billion figure belongs mostly to government programs, and individual awards are the modest trust amounts. Third, that Purdue still exists — it has dissolved, its operations continuing under a new entity, Knoa Pharma LLC, with the Sacklers barred from selling opioids in the United States and stripped of control. The settlement's strongest accountability measures are structural: public release of company documents including attorney-client privileged materials, monitored limits on Purdue's lobbying and marketing, and the family's permanent exit from opioid sales.
Who Benefits From This — and Who Does Not
Who benefits most from this guide:
People who filed a proof of claim in the Purdue bankruptcy by July 30, 2020 and then submitted a claim form to the trust by July 28, 2025. How: Qualified and Allowed claimants are paid on a rolling basis, with initial awards of 16,294 dollars for a Non-NAS Tier 1 claim, 8,147 dollars for a Non-NAS Tier 2 claim, and 25,653 dollars for a neonatal abstinence syndrome claim, before attorney fees and medical liens.
Neonatal abstinence syndrome claimants. How: the NAS tier carries the highest initial award, at 25,653 dollars before fees and liens.
Claimants without a lawyer. How: the trust contacts unrepresented claimants by email, and most Qualified and Allowed claimants were expected to receive at least part of their award before the end of 2026.
Who does not benefit:
Anyone who never filed a claim. How: the window to file a new personal-injury claim closed July 28, 2025, and no new individual claimants can enter the process now.
Anyone expecting a share of the full 7.4 billion dollars. How: most of the 7.4 billion funds government abatement programs, while individuals share a roughly 865 million dollar pool run by the Purdue Personal Injury Trust.
Anyone expecting the Sacklers to have admitted wrongdoing. How: the settlement resolves claims without any admission of liability, and the releases are consensual, covering only creditors who affirmatively opted in by March 1, 2026.
Another settlement where only timely filers can be paid is covered in our guide to the Camp Lejeune lawsuit, where the filing window closed on August 10, 2024.
Frequently Asked Questions
How much do Purdue opioid victims get in 2026?
The Purdue Personal Injury Trust set initial awards on September 30, 2026: $16,294 for a Non-NAS Tier 1 claim, $8,147 for a Non-NAS Tier 2 claim, and $25,653 for a neonatal abstinence syndrome claim — before attorney fees and medical liens. A second distribution is possible later.
Can I still file a claim in the Purdue opioid settlement?
No. The window to file a new personal-injury claim closed July 28, 2025, and eligibility required a proof of claim in the bankruptcy by July 30, 2020. No new individual claimants can enter the process.
When do victims get paid?
The plan took effect May 1, 2026, and the trust is paying Qualified and Allowed claimants on a rolling basis, expecting most to receive at least part of their award before the end of 2026. Claimants without a lawyer are contacted by email to confirm a mailing address.
Did the Sacklers admit wrongdoing?
No. The settlement resolves claims without any admission of liability, and no court has found any Sackler family member liable. The releases in the plan are consensual: only creditors who affirmatively opted in by March 1, 2026 released their claims against the Sackler parties.
Who benefits from the Purdue Personal Injury Trust?
People who filed a proof of claim by July 30, 2020 and a trust claim form by July 28, 2025 benefit, because only Qualified and Allowed claimants are paid from the roughly 865 million dollar pool, with initial awards of 16,294 dollars, 8,147 dollars, or 25,653 dollars depending on tier.
Who gets nothing from the Purdue settlement?
Anyone who never filed a claim gets nothing, because the window to file a new personal-injury claim closed July 28, 2025. People expecting a share of the full 7.4 billion dollars will also be disappointed, since most of that money funds government abatement programs.
Related Coverage
Pharmaceutical settlements follow familiar playbooks. See how other drug litigations resolved — or didn't — in our Belviq lawsuit 2026 coverage, the EzriCare eye drops outbreak litigation, and the Elmiron October 2026 update. For visual explainers on how these cases work, see Problem Solved.
Disclaimer: This article is general information, not legal or financial advice. Settlement details depend on the court-approved plan and individual circumstances; consult a qualified attorney before acting.